The oxygen therapy market would grow at a CAGR of 5.38% over the predicted time frame. The market is expected to increase in value from US$ 35.58 Bn in 2022 to US$ 60.08 Bn in 2032.

The on oxygen therapy Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2582

A recent report provides crucial insights along with application based and forecast information in the Global Oxygen therapy Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Oxygen therapy market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Oxygen therapy market are included as given below:

Oxygen therapy Market Key Players

• Philips Healthcare
• Linde Healthcare
• Chart Industries, Inc.
• Invacare Corporation
• Becton, Dickinson, and Company
• Smiths Medical
• Drägerwerk AG & Co. KGaA
• Teleflex Incorporated
• Fisher & Paykel Healthcare Corporation Limited
• DeVilbiss Healthcare
• HERSILL, S.L.
• GCE Holding AB

Market Segments

By Product

• Oxygen Source Equipment
  • Oxygen Therapy Equipment for Cardiovascular & Thoracic Surgeries
  • Oxygen Concentrators
  • Liquid Oxygen
  • Oxygen Cylinders
• Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannulas
  • Venturi Masks
  • Non-Rebreather Masks
  • Bag-Valve Masks
  • Other Oxygen Delivery Devices

By Portability

• Stationary Oxygen Therapy Equipment Devices
• Portable Oxygen Therapy Equipment Devices

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Report Objectives

• To define, describe, and forecast the global oxygen therapy market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the oxygen therapy market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oxygen Therapy Market 

5.1. COVID-19 Landscape: Oxygen Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oxygen Therapy Market, By Product

8.1. Oxygen Therapy Market, by Product, 2023-2032

8.1.1 Oxygen Source Equipment

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Oxygen Delivery Devices

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Oxygen Therapy Market, By Portability

9.1. Oxygen Therapy Market, by Portability, 2023-2032

9.1.1. Stationary Oxygen Therapy Equipment Devices

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Portable Oxygen Therapy Equipment Devices

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Oxygen Therapy Market, By Application 

10.1. Oxygen Therapy Market, by Application, 2023-2032

10.1.1. Chronic Obstructive Pulmonary Disease

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Asthma

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Obstructive Sleep Apnea

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Respiratory Distress Syndrome

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Cystic Fibrosis

10.1.5.1. Market Revenue and Forecast (2020-2032)

10.1.6. Pneumonia

10.1.6.1. Market Revenue and Forecast (2020-2032)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Oxygen Therapy Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Portability (2020-2032)

11.1.3. Market Revenue and Forecast, by Application (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Portability (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Application (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Portability (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Portability (2020-2032)

11.2.3. Market Revenue and Forecast, by Application (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Portability (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Application (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Portability (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Portability (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Portability (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Portability (2020-2032)

11.3.3. Market Revenue and Forecast, by Application (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Portability (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Application (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Portability (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Portability (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Portability (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Portability (2020-2032)

11.4.3. Market Revenue and Forecast, by Application (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Portability (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Application (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Portability (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Portability (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Portability (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Portability (2020-2032)

11.5.3. Market Revenue and Forecast, by Application (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Portability (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Application (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Portability (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

Chapter 12. Company Profiles

12.1. Philips Healthcare

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Linde Healthcare

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Chart Industries, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Invacare Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Becton, Dickinson, and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Smiths Medical

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Drägerwerk AG & Co. KGaA

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Teleflex Incorporated

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Fisher & Paykel Healthcare Corporation Limited

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. DeVilbiss Healthcare

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com